Average Co-Inventor Count = 4.82
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Elan Pharmaceuticals, Inc. (11 from 202 patents)
2. Pharmacia & Upjohn Company (5 from 523 patents)
3. University of California (3 from 15,502 patents)
4. Nantneuro, LLC (2 from 2 patents)
5. Pharmacia & Upjohn (1 from 117 patents)
6. Buck Institute for Research on Aging (49 patents)
16 patents:
1. 12441716 - Compositions and methods for increasing muscle mass and oxidative metabolism
2. 12157740 - Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau
3. 11370793 - Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau
4. 11142505 - Compositions for APP-selective BACE inhibition and uses therefor
5. 11077108 - Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition
6. 7906556 - Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
7. 7858642 - Substituted hydroxyethylamine aspartyl protease inhibitors
8. 7727997 - N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
9. 7498436 - Substituted hydroxyethylamines
10. 7385085 - Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
11. 7338965 - 3,4-disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines
12. 7294642 - 1,3-Diamino-2-hydroxypropane pro-drug derivatives
13. 7214715 - Compounds to treat Alzheimer's disease
14. 7176242 - N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
15. 6962934 - Substituted amino carboxamides for the treatment of Alzheimer's disease